KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHC) Cash from Financing Activities (2016 - 2025)

Diversified Healthcare Trust (DHC) has disclosed Cash from Financing Activities for 17 consecutive years, with -$275.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 332.57% year-over-year to -$275.1 million, compared with a TTM value of -$492.0 million through Dec 2025, down 2105.23%, and an annual FY2025 reading of -$492.0 million, down 2105.23% over the prior year.
  • Cash from Financing Activities was -$275.1 million for Q4 2025 at Diversified Healthcare Trust, down from $104.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.1 billion in Q1 2021 and bottomed at -$538.4 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is -$34.7 million, with a median of -$15.8 million recorded in 2021.
  • The sharpest move saw Cash from Financing Activities surged 32214.79% in 2021, then tumbled 1430.77% in 2025.
  • Year by year, Cash from Financing Activities stood at -$9.9 million in 2021, then crashed by 31.61% to -$13.1 million in 2022, then soared by 301.1% to $26.3 million in 2023, then tumbled by 341.56% to -$63.6 million in 2024, then plummeted by 332.57% to -$275.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for DHC at -$275.1 million in Q4 2025, $104.2 million in Q3 2025, and -$190.0 million in Q2 2025.